MetaADEDB 2.0 @ LMMD
Tramadol
(TVYLLZQTGLZFBW-UHFFFAOYSA-N)
Structure
SMILES
COc1cccc(c1)C1(O)CCCCC1CN(C)C
Molecular Formula:
C16H25NO2
Molecular Weight:
263.375
Log P:
2.6346
Hydrogen Bond Acceptor:
3
Hydrogen Bond Donor:
1
TPSA:
32.7
CAS Number(s):
2914-77-4
Synonym(s)
1.
Tramadol
2.
Adolonta
3.
Amadol
4.
Biodalgic
5.
Biokanol
6.
Contramal
7.
Jutadol
8.
K-315
9.
MTW-Tramadol
10.
Nobligan
11.
Prontofort
12.
Ranitidin 1A Pharma
13.
Takadol
14.
Theradol
15.
Tiral
16.
Topalgic
17.
Tradol
18.
Tradol-Puren
19.
Tradonal
20.
Tralgiol
21.
Trama 1A Pharma
22.
Trama AbZ
23.
Trama KD
24.
Trama-Dorsch
25.
Tramabeta
26.
Tramadin
27.
Tramadoc
28.
Tramadol 1A
29.
Tramadol AL
30.
Tramadol Asta Medica
31.
Tramadol Basics
32.
Tramadol Bayvit
33.
Tramadol Bexal
34.
Tramadol Cinfa
35.
Tramadol Edigen
36.
Tramadol Heumann
37.
Tramadol Hydrochloride
38.
Tramadol Kern
39.
Tramadol Lichtenstein
40.
Tramadol Lindo
41.
Tramadol Mabo
42.
Tramadol Normon
43.
Tramadol PB
44.
Tramadol Ratiopharm
45.
Tramadol Stada
46.
Tramadol acis
47.
Tramadol-Dolgit
48.
Tramadol-Hameln
49.
Tramadol-ratiopharm
50.
Tramadolor
51.
Tramadura
52.
Tramagetic
53.
Tramagit
54.
Tramake
55.
Tramal
56.
Tramex
57.
Tramundin
58.
Trasedal
59.
Ultram
60.
Xymel 50
61.
Zamudol
62.
Zumalgic
63.
Zydol
64.
Zytram
65.
K 315
66.
K315
67.
MTW Tramadol
68.
MTWTramadol
69.
Tradol Puren
70.
TradolPuren
71.
Trama Dorsch
72.
TramaDorsch
73.
Tramadol Dolgit
74.
Tramadol Hameln
75.
TramadolDolgit
76.
TramadolHameln
77.
Tramadolratiopharm
External Link(s)
MeSHD014147
PubChem Compound5523
ChEBI75722
CHEMBLCHEMBL1237044
IUPHAR/BPS Guide to PHARMACOLOGY8286
Therapeutic Target DatabaseD05GKD
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1Drug abuserFAERS: 160US FAERS
2Drug DependenceFAERS: 67
Canada Vigilance: 1
Canada Vigilance
US FAERS
3NauseaFAERS: 66
Canada Vigilance: 3
Canada Vigilance
US FAERS
4Drug ineffectiveFAERS: 61
Canada Vigilance: 2
Canada Vigilance
US FAERS
5VomitingFAERS: 45
Canada Vigilance: 1
Canada Vigilance
US FAERS
6Drug withdrawal syndromeFAERS: 41US FAERS
7DizzinessFAERS: 37
Canada Vigilance: 3
Canada Vigilance
US FAERS
8OverdoseFAERS: 37US FAERS
9PruritusFAERS: 33
Canada Vigilance: 1
Canada Vigilance
US FAERS
10PainFAERS: 30US FAERS
11Pharmaceutical product complaintFAERS: 30US FAERS
12HypersensitivityFAERS: 29US FAERS
13Feeling abnormalFAERS: 28US FAERS
14HeadacheFAERS: 24US FAERS
15TremorFAERS: 19
Canada Vigilance: 3
Canada Vigilance
US FAERS
16UrticariaFAERS: 19US FAERS
17SomnolenceFAERS: 15US FAERS
18Abdominal discomfortFAERS: 14US FAERS
19Myocardial InfarctionFAERS: 14US FAERS
20Adverse eventFAERS: 11US FAERS
21Drug screen positiveFAERS: 11US FAERS
22MalaiseFAERS: 11US FAERS
23AstheniaFAERS: 10
Canada Vigilance: 1
Canada Vigilance
US FAERS
24FatigueFAERS: 10US FAERS
25Weight decreasedFAERS: 10US FAERS
26Depressed Level of ConsciousnessFAERS: 9US FAERS
27Drug dose omissionFAERS: 9US FAERS
28AmnesiaFAERS: 8US FAERS
29AngerFAERS: 8US FAERS
30AnxietyFAERS: 8US FAERS
31HypotensionFAERS: 8US FAERS
32LethargyFAERS: 8US FAERS
33Suicide attemptFAERS: 8US FAERS
34TachycardiaFAERS: 8US FAERS
35Unresponsive to stimuliFAERS: 8US FAERS
36AgitationFAERS: 7
Canada Vigilance: 1
Canada Vigilance
US FAERS
37Incorrect dose administeredFAERS: 7US FAERS
38Therapeutic response unexpected with drug substitutionFAERS: 7US FAERS
39VertigoFAERS: 7US FAERS
40Inadequate analgesiaFAERS: 6US FAERS
41Medication ErrorFAERS: 6US FAERS
42Product substitution issueFAERS: 6US FAERS
43Respiratory DepressionFAERS: 6US FAERS
44Wrong technique in product usage processFAERS: 6US FAERS
45Cardiac ArrestFAERS: 5US FAERS
46Chest PainFAERS: 5US FAERS
47ChillsFAERS: 5US FAERS
48ConstipationFAERS: 5US FAERS
49Drug administration errorFAERS: 5US FAERS
50Drug dispensing errorFAERS: 5US FAERS
51Drug exposure during pregnancyFAERS: 5US FAERS
52Memory impairmentFAERS: 5US FAERS
53NervousnessFAERS: 5US FAERS
54PalpitationsFAERS: 5US FAERS
55Abdominal PainFAERS: 4US FAERS
56CryingFAERS: 4US FAERS
57DependenceFAERS: 4US FAERS
58Drug withdrawal convulsionsFAERS: 4US FAERS
59FlushingFAERS: 4US FAERS
60Head discomfortFAERS: 4US FAERS
61Inappropriate schedule of drug administrationFAERS: 4US FAERS
62Multiple allergiesFAERS: 4US FAERS
63PneumoniaFAERS: 4US FAERS
64Restless Legs SyndromeFAERS: 4US FAERS
65SwellingFAERS: 4US FAERS
66SyncopeFAERS: 4US FAERS
67Therapeutic response unexpectedFAERS: 4US FAERS
68Completed SuicideFAERS: 3US FAERS
69Drug abuseFAERS: 3US FAERS
70Drug toxicityFAERS: 3US FAERS
71ErythemaFAERS: 3US FAERS
72Intentional drug misuseFAERS: 3US FAERS
73Intentional product misuseFAERS: 3US FAERS
74Middle insomniaFAERS: 3US FAERS
75OsteoporosisFAERS: 3US FAERS
76PresyncopeFAERS: 3US FAERS
77RestlessnessFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
78Therapy cessationFAERS: 3US FAERS
79TinnitusFAERS: 3
Canada Vigilance: 2
Canada Vigilance
US FAERS
80Wrong technique in drug usage processFAERS: 3US FAERS
81Alanine Aminotransferase IncreasedFAERS: 2US FAERS
82ArthralgiaFAERS: 2US FAERS
83ArthritisFAERS: 2US FAERS
84Aspartate Aminotransferase IncreasedFAERS: 2US FAERS
85Blood chloride decreasedFAERS: 2US FAERS
86Blood creatinine increasedFAERS: 2US FAERS
87Calcium deficiencyFAERS: 2US FAERS
88Cerebrovascular accidentFAERS: 2US FAERS
89Chest discomfortFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
90DehydrationFAERS: 2US FAERS
91DiplegiaFAERS: 2US FAERS
92DisorientationFAERS: 2US FAERS
93Drug ToleranceFAERS: 2US FAERS
94Drug diversionFAERS: 2US FAERS
95Drug screen false positiveFAERS: 2US FAERS
96DysuriaFAERS: 2US FAERS
97Euphoric moodFAERS: 2US FAERS
98Feeling jitteryFAERS: 2US FAERS
99FrustrationFAERS: 2US FAERS
100Gastrointestinal PainFAERS: 2US FAERS
101General physical health deteriorationFAERS: 2US FAERS
102HepatitisFAERS: 2US FAERS
103HypoventilationFAERS: 2US FAERS
104Impaired work abilityFAERS: 2US FAERS
105Intentional misuseFAERS: 2US FAERS
106Mental impairmentFAERS: 2US FAERS
107Mental status changesFAERS: 2US FAERS
108Nephrogenic Diabetes InsipidusFAERS: 2US FAERS
109NeuralgiaFAERS: 2US FAERS
110Opiates positiveFAERS: 2US FAERS
111Pancreatic enzyme abnormalityFAERS: 2US FAERS
112Poor quality sleepFAERS: 2US FAERS
113Prescribed overdoseFAERS: 2US FAERS
114Product use issueFAERS: 2US FAERS
115Respiratory FailureFAERS: 2US FAERS
116ScreamingFAERS: 2US FAERS
117SneezingFAERS: 2US FAERS
118StressFAERS: 2US FAERS
119Sudden deathFAERS: 2US FAERS
120Therapy non-responderFAERS: 2US FAERS
121Throat irritationFAERS: 2US FAERS
122Urinary IncontinenceFAERS: 2US FAERS
123treatment failureFAERS: 2US FAERS
124Acanthosis NigricansFAERS: 1US FAERS
125Accidental exposure to productFAERS: 1US FAERS
126Accidental exposureFAERS: 1US FAERS
127Accidental overdoseFAERS: 1US FAERS
128AcneFAERS: 1US FAERS
129Altered visual depth perceptionFAERS: 1US FAERS
130Anaphylactic shockFAERS: 1US FAERS
131Anaphylactoid ReactionFAERS: 1US FAERS
132AngioedemaFAERS: 1US FAERS
133AnorexiaFAERS: 1US FAERS
134ApathyFAERS: 1US FAERS
135ArthropathyFAERS: 1US FAERS
136Back PainFAERS: 1US FAERS
137BedriddenFAERS: 1US FAERS
138Bipolar DisorderFAERS: 1US FAERS
139Blood albumin decreasedFAERS: 1US FAERS
140Blood creatine phosphokinase increasedFAERS: 1US FAERS
141Blood follicle stimulating hormone increasedFAERS: 1US FAERS
142Blood potassium decreasedFAERS: 1US FAERS
143Blood potassium increasedFAERS: 1US FAERS
144BradycardiaFAERS: 1US FAERS
145BradyphreniaFAERS: 1US FAERS
146BruxismFAERS: 1US FAERS
147Burning sensationFAERS: 1US FAERS
148CataractFAERS: 1US FAERS
149CholelithiasisFAERS: 1US FAERS
150Cold sweatFAERS: 1US FAERS
151Deep Vein ThrombosisFAERS: 1US FAERS
152DementiaFAERS: 1US FAERS
153DisabilityFAERS: 1US FAERS
154DiscomfortFAERS: 1US FAERS
155Disease recurrenceFAERS: 1US FAERS
156DiverticulumFAERS: 1US FAERS
157Drug effect incompleteFAERS: 1US FAERS
158Drug ineffective for unapproved indicationFAERS: 1US FAERS
159Drug screen negativeFAERS: 1US FAERS
160Drug therapy changedFAERS: 1US FAERS
161DysarthriaFAERS: 1US FAERS
162DysgeusiaFAERS: 1US FAERS
163DyspepsiaFAERS: 1US FAERS
164Ear discomfortFAERS: 1US FAERS
165Electrolyte imbalanceFAERS: 1US FAERS
166Emotional distressFAERS: 1US FAERS
167EructationFAERS: 1US FAERS
168Expired product administeredFAERS: 1US FAERS
169Eye painFAERS: 1US FAERS
170FibromyalgiaFAERS: 1US FAERS
171FormicationFAERS: 1US FAERS
172GastritisFAERS: 1US FAERS
173Hallucinations, mixedFAERS: 1US FAERS
174Hepatitis AFAERS: 1US FAERS
175HypersomniaFAERS: 1US FAERS
176HypogonadismFAERS: 1US FAERS
177Impaired driving abilityFAERS: 1US FAERS
178Impaired self-careFAERS: 1US FAERS
179Incorrect product storageFAERS: 1US FAERS
180InfectionFAERS: 1US FAERS
181InflammationFAERS: 1US FAERS
182Initial insomniaFAERS: 1US FAERS
183Intentional product use issueFAERS: 1US FAERS
184Intentional self-injuryFAERS: 1US FAERS
185Intervertebral Disc DegenerationFAERS: 1US FAERS
186Limb injuryFAERS: 1US FAERS
187Lip exfoliationFAERS: 1US FAERS
188Lip swellingFAERS: 1US FAERS
189Livedo ReticularisFAERS: 1US FAERS
190MYELODYSPLASTIC SYNDROMEFAERS: 1US FAERS
191Macular degenerationFAERS: 1US FAERS
192MenopauseFAERS: 1US FAERS
193Mood swingsFAERS: 1US FAERS
194MurderFAERS: 1US FAERS
195Muscle RigidityFAERS: 1US FAERS
196Musculoskeletal stiffnessFAERS: 1US FAERS
197NarcolepsyFAERS: 1US FAERS
198NasopharyngitisFAERS: 1US FAERS
199Neonatal disorderFAERS: 1US FAERS
200NephrolithiasisFAERS: 1US FAERS
201Night sweatsFAERS: 1US FAERS
202Nuchal RigidityFAERS: 1US FAERS
203Open woundFAERS: 1US FAERS
204PallorFAERS: 1US FAERS
205Pancreatic InsufficiencyFAERS: 1US FAERS
206PancreatitisFAERS: 1US FAERS
207ParanoiaFAERS: 1US FAERS
208ParesisFAERS: 1US FAERS
209Peripheral swellingFAERS: 1US FAERS
210Pharmaceutical product counterfeitFAERS: 1US FAERS
211PhotophobiaFAERS: 1US FAERS
212PiloerectionFAERS: 1US FAERS
213Polysubstance abuseFAERS: 1US FAERS
214Post procedural complicationFAERS: 1US FAERS
215Post-Traumatic Stress DisorderFAERS: 1US FAERS
216Post-traumatic neck syndromeFAERS: 1US FAERS
217Product availability issueFAERS: 1US FAERS
218Product dose omissionFAERS: 1US FAERS
219Product label confusionFAERS: 1US FAERS
220Product quality issueFAERS: 1US FAERS
221Product use in unapproved indicationFAERS: 1US FAERS
222Rash erythematousFAERS: 1US FAERS
223Refusal of treatment by relativeFAERS: 1US FAERS
224Renal painFAERS: 1US FAERS
225Root canal infectionFAERS: 1US FAERS
226SciaticaFAERS: 1US FAERS
227Sedation complicationFAERS: 1US FAERS
228SepsisFAERS: 1US FAERS
229StridorFAERS: 1US FAERS
230Systemic Inflammatory Response SyndromeFAERS: 1US FAERS
231Therapy changeFAERS: 1US FAERS
232Thermal burnFAERS: 1US FAERS
233ToothacheFAERS: 1US FAERS
234TrismusFAERS: 1US FAERS
235Troponin increasedFAERS: 1US FAERS
236Urinary RetentionFAERS: 1US FAERS
237Urinary hesitationFAERS: 1US FAERS
238Visual ImpairmentFAERS: 1US FAERS
239Wrong drug administeredFAERS: 1US FAERS
240Wrong patient received medicationFAERS: 1US FAERS
241YawningFAERS: 1US FAERS
242nervous system disorderFAERS: 1US FAERS
243Claudication of jaw musclesCanada Vigilance: 1Canada Vigilance
244HyperkinesiaCanada Vigilance: 1Canada Vigilance
245OtotoxicityCanada Vigilance: 1Canada Vigilance
246RetchingCanada Vigilance: 1Canada Vigilance
247Serotonin SyndromeCanada Vigilance: 1Canada Vigilance
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120239

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.